Year Founded
2022
Ownership
Private
Employees
~10
Stage
Preclinical
Modalities
Small molecule

Olio Labs General Information

Generated combinations that outperform 5 best-in-class monotherapies in preclinical models across obesity and oncology indications

Contact Information

Website
Primary Industry
Biotech
Corporate Office

Drug Pipeline

No pipeline data available

For full access to Olio Labs's pipeline data

Book a demo

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Olio Labs Funding

Deal TypeDateAmountStatusStage
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Olio Labs's complete valuation and funding history, request access »

Olio Labs Investors

Boom Capital [6]
Investor Type: Venture Capital
Holding: Minority
Overwater Ventures [6]
Investor Type: Venture Capital
Holding: Minority
Pioneer Fund [2][6]
Investor Type: Venture Capital
Holding: Minority
Investor Name
Investor Type
Holding
Investor Name
Investor Type
Holding
You're viewing 3 of 7 investors. Get the full list »